Eskapee pathogens antigen research and development services
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0145
- Awardee
-
Green Mountain Antibodies, Inc. UEI FVQDNC5PJ5P3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $137,050
Award facts
- Opportunity
-
- Services to Develop Antibodies against ESKAPEE Pathogens_NOI_to_Sole Source Special Notice · W81XWH20R0082 · Posted Jul 8, 2020
- ESKAPEE Pathogens Limited / Sole Source Justification · Posted Sep 23, 2020
- Contract value 11% obligated
- $1,264,126.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Burlington, VT 05401, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $273,260 | |
| Supplemental Agreement for work within scope | $265,570 | |
| Exercise an Option | $257,900 | |
| Supplemental Agreement for work within scope | $330,346 | |
| Change Order | $0 | |
| Original award | $137,050 |
About this award
Green Mountain Antibodies Inc. was awarded a firm fixed-price definitive contract valued at $1.26 million by the Defense Health Agency on September 30, 2020, to develop monoclonal antibodies against ESKAPEE (Enterococcus, Staphylococcus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter, and Escherichia) pathogens. The work will be performed in Burlington, Vermont, and is scheduled for completion by December 29, 2025. This non-personal services contract originated from a Special Notice solicitation posted by the Department of the Army Medical Command, specifically the Walter Reed Army Institute of Research (WRAIR), which sought a small business contractor through a total small business set-aside designation. No set-aside was ultimately used for the award itself.
Under this contract, Green Mountain Antibodies will provide antibody development services including immunization of mice with target antigens, generation and screening of hybridoma libraries via ELISA, and delivery of purified monoclonal antibodies suitable for in vitro and in vivo testing. The work supports WRAIR's Wound Infections Department and Bacterial Diseases Branch, assisting the Department of Defense in developing medical countermeasures against multidrug-resistant bacterial pathogens that pose significant threats to military medical readiness and force health protection. The original solicitation contemplated a one-year base period with four optional one-year extensions.
Quick answers
Who was awarded contract W81XWH20C0145?
W81XWH20C0145 was awarded to Green Mountain Antibodies, Inc. by Defense Health Agency (Department of Defense) on September 30, 2020.
How much is contract W81XWH20C0145 worth?
The government has obligated $137,050 on W81XWH20C0145. Its current value, with exercised options, is $1,264,126.
Was contract W81XWH20C0145 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award